¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"diffuse cutaneous mastocytosis"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • diffuse Lewy body disease
    ±¤¹üÀ§·¹ºñ¼Òüº´
  • diffuse placenta
    ÆÛÁøÅ¹Ý
  • diffuse proliferative glomerulonephritis
    ±¤¹üÀ§Áõ½ÄÅ丮ÄáÆÏ¿°, ±¤¹üÀ§Áõ½Ä»ç±¸Ã¼½Å¿°
  • diffuse reflection
    ±¤¹üÀ§¹Ý»ç
  • diffuse scleritis
    ±¤¹üÀ§°ø¸·¿°
  • diffuse scleroderma
    ±¤¹üÀ§ÇǺΰæÈ­Áõ
  • diffuse sclerosis
    ±¤¹üÀ§°æÈ­Áõ
  • diffuse systemic sclerosis
    ±¤¹üÀ§Àü½Å°æÈ­Áõ
  • progressive diffuse keratoderma
    ±¤¹üÀ§ÁøÇà°¢ÁúÇǺÎÁõ
  • subacute diffuse glomerulonephritis
    ¾Æ±Þ¼º»êÀçÅ丮ÄáÆÏ¿°, ¾Æ±Þ¼º¹ü¹ß»ç±¸Ã¼½Å¿°
  • cutaneous
    ÇǺÎ-
  • cutaneous allergy
    ÇǺξ˷¹¸£±â
  • cutaneous asthma
    ÇǺÎõ½Ä
  • cutaneous basophil hypersensitivity
    ÇǺÎÈ£¿°±¸°ú¹Î(Áõ)
  • cutaneous drug reaction
    ÇǺξ๰¹ÝÀÀ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • diffuse scleritis
    ±¤¹üÀ§°ø¸·¿°
  • diffuse scleroderma
    ±¤¹üÀ§ÇǺΰæÈ­Áõ
  • diffuse sclerosis
    ±¤¹üÀ§°æÈ­Áõ
  • diffuse cerebral sclerosis
    ±¤¹üÀ§³ú°æÈ­Áõ
  • diffuse collagen disease
    ±¤¹üÀ§¾Æ±³Áúº´, ¹Ì¸¸¾Æ±³Áúº´
  • diffuse esophageal spasm
    È®»ê½Äµµ¿¬Ãà
  • diffuse interstitial pulmonary disease
    ±¤¹üÀ§»çÀÌÁúÆóº´, ¹Ì¸¸°£ÁúÆóº´
  • diffuse proliferative glomerulonephritis
    »êÀçÁõ½ÄÅ丮ÄáÆÏ¿°, ¹Ì¸¸Áõ½Ä»ç±¸Ã¼½Å¿°
  • diffuse systemic sclerosis
    ±¤¹üÀ§Àü½Å°æÈ­Áõ
  • subacute diffuse glomerulonephritis
    ¾Æ±Þ¼º»êÀçÅ丮ÄáÆÏ¿°, ¾Æ±Þ¼º¹ü¹ß»ç±¸Ã¼½Å¿°
  • progressive diffuse keratoderma
    ±¤¹üÀ§ÁøÇà°¢ÁúÇǺÎÁõ
  • cutaneous allergy
    ÇǺξ˷¹¸£±â
  • cutaneous asthma
    ÇǺÎõ½Ä
  • passive cutaneous anaphylaxis
    ¼öµ¿ÇǺξƳªÇʶô½Ã½º
  • cutaneous
    ÇǺÎ-
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • posterior cutaneous nerve of arm
    µÚÀ§ÆÈÇǺνŰæ
  • posterior cutaneous nerve of forearm
    µÚ¾Æ·¡ÆÈÇǺνŰæ
  • posterior femoral cutaneous nerve
    µÚ³Ò´Ù¸®ÇǺνŰæ
  • primary cutaneous adenocystic carcinoma
    ¿ø¹ß¼º ÇǺΠ¼±³¶Á¾¼º¾Ï
  • primary localized cutaneous amyloidosis
    ¿ø¹ß¼º ±¹¼Ò ÇǺΠÀ¯ÀüºÐÁõ
  • random cutaneous flap
    ÀÓÀÇÇÇÆÇ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • diffuse atelectasis
    ¹Ì¸¸¼º ¹«±âÆó.
  • diffuse atrophy of alveolar bone
    ¹Ì¸¸¼º Ä¡Á¶°ñÀ§Ãà(¡­öÍðËÍéê×õê).
  • diffuse axonal injury
    ¹Ì¸¸¼º Ãà»è¼Õ»ó
  • diffuse bronchiolitis
    ¹Ì¸¸¼º ¼¼±â°üÁö¿°.
  • diffuse cerebral atrophy
    ¹Ì¸¸¼º ³úÀ§Ãà.
  • diffuse cerebral sclerosis
    ¹Ì¸¸¼º ³ú°æÈ­Áõ.
  • diffuse collagen disease
    ¹Ì¸¸¼º ±³¿øº´.
  • diffuse elastoma of Dubreuilh
    µàºê·çÀÌ ±¤¹üÀ§ ź·Â ¼¶À¯Á¾
  • diffuse esophageal spasm
    ¹Ì¸¸¼º½Äµµ°æ·Ã, ¹Ì¸¸¼º½Äµµ¿¬Ãà.
  • diffuse exfoliative erythroderma
    ¹Ì¸¸¼º<¹ü¹ß¼º> ¹Ú¸®¼º È«ÇÇÁõ.
  • diffuse external otitis
    ¹ü¹ß(¼º) ¿ÜÀ̵µ¿°
  • diffuse familial comedo
    ±¤¹üÀ§ °¡Á·¼º ¸éÆ÷
  • diffuse fascitis
  • diffuse goiter
    ¹Ì¸¸¼º °©»ó¼±Á¾(¡­°©»ó¼±Á¾).
  • diffuse goiter
    ¹Ì¸¸¼º °©»ó¼±Á¾(¡­Ë£ßÒàÍðþ).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Medial cutaneous nerve of forearm
    ¾ÈÂʾƷ¡ÆÈÇǺνŰæ
    [¿¾ ¿ë¾î] ³»ÃøÀü¿ÏÇǽŰæ
  • Medial cutaneous nerve of arm
    ¾ÈÂÊÀ§ÆÈÇǺνŰæ
    [¿¾ ¿ë¾î] ³»Ãø»ó¿ÏÇǽŰæ
  • Medial sural cutaneous nerve
    ¾ÈÂÊÀåµýÁöÇǺνŰæ
    [¿¾ ¿ë¾î] ³»Ãøºñº¹ÇǽŰæ
  • Medial cutaneous branches of leg
    ¾ÈÂÊÁ¾¾Æ¸®ÇǺΰ¡Áö
    [¿¾ ¿ë¾î] ³»ÃøÇÏÅðÇÇÁö
  • Medial cutaneous branch
    ¾ÈÂÊÇǺΰ¡Áö
    [¿¾ ¿ë¾î] ³»ÃøÇÇÁö
  • Anterior cutaneous branch (of thorax)
    ¾Õ(°¡½¿)ÇǺΰ¡Áö
    [¿¾ ¿ë¾î] Àü(Èä)ÇÇÁö
  • Anterior cutaneous branch (of abdomen)
    ¾Õ(¹è)ÇǺΰ¡Áö
    [¿¾ ¿ë¾î] Àü(º¹)ÇÇÁö
  • Anterior cutaneous branch
    ¾ÕÇǺΰ¡Áö
    [¿¾ ¿ë¾î] ÀüÇÇÁö
  • Anterior cutaneous branches
    ¾ÕÇǺΰ¡Áö
    [¿¾ ¿ë¾î] ÀüÇÇÁö
  • Superior lateral cutaneous nerve of arm
    À§°¡ÂÊÀ§ÆÈÇǺνŰæ
    [¿¾ ¿ë¾î] »ó¿ÜÃø»ó¿ÏÇǽŰæ
  • Intermediate dorsal cutaneous nerve
    Áß°£¹ßµîÇǺνŰæ
    [¿¾ ¿ë¾î] ÁßÁ·¹èÇǽŰæ
  • Cutaneous branch
    ÇǺΰ¡Áö
    [¿¾ ¿ë¾î] ÇÇÁö
  • Cutaneous branches
    ÇǺΰ¡Áö
    [¿¾ ¿ë¾î] ÇÇÁö
  • Cutaneous sulci
    ÇǺΰí¶û
    [¿¾ ¿ë¾î] ÇǺμұ¸
  • Cutaneous muscle
    ÇǺαÙÀ°
    [¿¾ ¿ë¾î] ÇDZÙ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
OCA Oculo-Cutaneous Albinism
PCA   1) Passive Cutaneous Araphylaxis
  2) Posterior Cerebral Artery
PCNA Per-Cutaneous Needle Aspiration of lung
S.C. Sub Cutis; Sub-Cutaneous(ly) injection; ÇÇÇÏ·Î, ÇÇÇÏÁÖ»ç
SCLE Subacute Cutaneous Lupus Erythematosus
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
CFC Cardio-Facio-Cutaneous
CBCL Cutaneous B cell lymphoma
CL Cutaneous Leishmaniasis
CLA Cutaneous Lymphocyte-associated Antigen
CTCL Cutaneous T cell lymphoma
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • diffuse thickening
    ¹Ì¸¸¼º ºñÈÄ
  • diffuse waxy spleen
    ¹Ì¸¸¼º ³³ ºñ
    ºñÀåÀÇ ¾Æ¹Ð·ÎÀÌµå º¯¼ºÀ¸·Î¼­ ƯÈ÷ Á¤¸Æµ¿ÀÇ ¿ÜÃþ°ú ¸Á»ó Á¶Á÷ÀÌ Ä§½ÀµÈ °Í.
  • American cutaneous Leishmaniasis
    ¾Æ¸Þ¸®Ä« ÇǺΠ¸®½´¸¶´Ï¾Æº´
  • anterior cutaneous branch of abdomen
    ¾Õ¹è ÇǺΰ¡Áö
  • chronic infantile neurological cutaneous articular syndrome
    ¸¸¼º À¯¾Æ ½Å°æ ÇǺαº
  • cutaneous afferent
    ÇǺΠ±¸½É ½Å°æ
  • cutaneous artery
    ÇǺΠµ¿¸Æ
  • cutaneous B cell lymphoma
    ÇǺΠB ¼¼Æ÷ ¸²ÇÁÁ¾
  • cutaneous burn
    ÇǺΠȭ»ó
  • cutaneous circulation
    ÇǺΠ¼øÈ¯
  • cutaneous gland
    ÇǺΠ¼±
  • cutaneous hyperactivity
    ÇǺΠ°ú¹Î ¹ÝÀÀ
  • cutaneous hypersensitivity
    ÇǺΠ°ú¹ÎÁõ
  • cutaneous lupus erythematosus
    ÇǺΠȫ¹Ý¼º ·çÇÁ½º
  • cutaneous lymphoblastoma
    ÇǺΠ¸²ÇÁ¾Æ¼¼Æ÷Á¾
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
diffuse brain atrophy A form of dementia caused by destruction (atrophy) of the frontal lobes of the brain. This condition leads to the progressive deterioration of mental functioning.
Incidence: 9 in 10,000 people in the general population.
(27 Sep 1997)
diffuse choroiditis A widespread exudative inflammation of the choroid, with progressive resolution of older lesions as new ones occur.
(05 Mar 2000)
diffuse deep keratitis An inflammation of the posterior corneal stroma.
Synonym: diffuse deep keratitis.
(05 Mar 2000)
diffuse emphysema Emphysema affecting all parts of the lobules, in part, or usually the whole, of the lungs, and usually associated with a1-antiprotease deficiency emphysema.
Synonym: diffuse emphysema, generalised emphysema, panacinar emphysema.
(05 Mar 2000)
diffuse gallbladder wall thickening <radiology> Criterion: gall bladder wall greater than 3 mm may appear thicker due to surrounding ascites, cholecystitis (acute or chronic), non-fasting state, chronic hypoalbuminaemia, hepatitis, congestive heart failure, fat in gall bladder fossa Cf: focal thickening
(12 Dec 1998)
diffuse ganglion A cystic swelling due to inflammatory effusion into one or several adjacent tendon sheaths.
(05 Mar 2000)
diffuse glomerulonephritis Glomerulonephritis affecting most of the renal glomeruli; it may lead to azotemia.
(05 Mar 2000)
diffuse goiter Goiter in which the morbid process involves the whole gland, as opposed to nodular goiter or thyroid adenoma.
(05 Mar 2000)
diffuse idiopathic skeletal hyperostosis A form of degenerative arthritis characteristically associated with flowing calcification along the sides of the vertebrae of the spine and commonly with inflammation (tendinitis) and calcification of the tendons at their attachments points to bone. Because areas of the spine and tendons can become inflamed, antiinflammatory medications (NSAIDs), such ibuprofen, can be helpful in both relieving pain and inflammation. Also called Forestier's disease.
(12 Dec 1998)
diffuse infantile familial sclerosis <radiology> Dysmyelinating disease, autosomal recessive, usually presents by 1 yr, specific enzyme deficiency identified, rapid spontaneous nystagmus, poikilothermia
Synonym: Krabbe leukodystrophy
(12 Dec 1998)
diffuse interstitial fibrosis Progressive fibrous changes and scarring within the lung tissue, eventually interfering with normal gas exchange.
(27 Sep 1997)
diffuse interstitial pulmonary fibrosis This represents a group of pulmonary disorders (lower respiratory tract) that leads to a functional loss in the alveolar air sacs and a compromise in the diffusion of oxygen from air to blood. There is widespread inflammation and scar tissue (fibrosis) formation within the lung. The causes are varied and include: inorganic and organic dusts, gases, fumes, vapors, infections, radiation, medications, coal dust, silicosis and byssinosis. When the cause is not identifiable it is referred to as idiopathic diffuse interstitial pulmonary fibrosis
(27 Sep 1997)
diffuse leishmaniasis Leishmaniasis caused by several New and Old World species and strains of Leishmania (L. Mexicana amazonensis, L. M. Pifanoi, possibly L. M. Garnhami and L. M. Venezuelensis; in Ethiopia, L. Aethiopica, and unidentified leishmanial agents in Namibia and Tanzania). The condition is associated with a suppressed cell-mediated immune response, so that the non-ulcerating, non-necrotizing cutaneous lesions can spread widely over the body; great numbers of parasite-filled macrophages are found in the dermal lesions. Healing does not appear to occur unless an acquired cellular hypersensitivity can develop.
Synonym: anergic leishmaniasis, diffuse leishmaniasis, disseminated cutaneous leishmaniasis, leishmaniasis tegumentaria diffusa, pseudolepromatous leishmaniasis.
(05 Mar 2000)
diffuse mesangial proliferation <nephrology, pathology> Inflammation of the kidney glomerulus (blood filtering portion of the kidney) due to the abnormal deposition of IgM antibody in the mesangium layer of the glomerular capillary. A form of glomerulonephritis that appears to be caused by an abnormal immune response. This disorder generally manifests as nephrotic syndrome.
Symptoms include swelling, dark urine, weight gain, hypertension, anorexia and bloody urine.
Acronym: MPGN
(05 Jan 1998)
diffuse nontoxic goitre A common cause of hyperthyroidism thought to be caused by an underlying autoimmune mechanism.
(27 Sep 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á